About Juvise Pharmaceutical
Juvise Pharmaceutical is a private limited company (BVBA/SPRL, legacy) based in Brussel, founded in 2003. For the 2025 financial year, Juvise Pharmaceutical reported a loss of €1,303. That makes 15 loss-making financial years in a row for Juvise Pharmaceutical. Revenue was not published, which is common for abbreviated accounts. The gross margin came to -€1,252. Equity is negative (-€227,678): liabilities exceed assets. In 2006 it was -€131,558. 20 annual accounts are available, covering 2006 to 2025.
- Activities
-
No results found
- Signals
-
Negative equityNegative equity € -228K
Equity is negative: debts exceed assets (technically insolvent).
Reporting lossesReporting losses € -1KThe company reported a loss in the latest financial year.
Poor liquidityPoor liquidity 0.00The current ratio is below 1: may be insufficient to cover short-term debt.
Negative cashflowNegative cashflow € -1KOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -1KEBITDA is negative: operating activities are loss-making.
Financial ratios
- Solvability > 25%
- -40,403.5%
- Liquidity > 1.0
- 0.00
- Profitability > 0%
- 0.6%
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
-1K
|
€
-2K
|
€
-1K
|
€
-1K
|
|
|
€
-1K
|
€
-2K
|
€
-1K
|
€
-1K
|
|
|
€
-1K
|
€
-2K
|
€
-2K
|
€
-1K
|
|
|
€
-228K
|
€
-226K
|
€
-224K
|
€
-223K
|
|
|
-40,403.48%
|
-30,857.21%
|
-55,712.44%
|
-52,586.14%
|
|
|
€
228K
|
€
227K
|
€
224K
|
€
223K
|
|
|
€
564
|
€
734
|
€
402
|
€
423
|
Publications 17
All publications- Me. - Comptes Annuels 31.12.2015, App 06.06.2016, Dpt 20.07.2016 16336-0307-008 26/07/2016
- Siege Social 28/06/2016
- Me. - Comptes Annuels 31.12.2014, App 01.06.2015, Dpt 22.06.2015 15199-0346-008 25/06/2015
- Me. - Comptes Annuels 31.12.2013, App 02.06.2014, Dpt 11.06.2014 14170-0470-009 18/06/2014
- Me. - Comptes Annuels 31.12.2012, App 03.06.2013, Dpt 22.07.2013 13333-0328-009 25/07/2013
Frequently asked questions
Answers to the most common questions about Juvise Pharmaceutical, based on official government data and the filed annual accounts.
What is the VAT number of Juvise Pharmaceutical?
The VAT number of Juvise Pharmaceutical is BE0863.588.327.
When was Juvise Pharmaceutical established?
Juvise Pharmaceutical was founded in 19-06-2003.
What is the official address of Juvise Pharmaceutical?
The official address of Juvise Pharmaceutical is Buro And Design Center, Heizel E 1/86 Brussel 1020.
What is the legal form of Juvise Pharmaceutical?
The juridical form of Juvise Pharmaceutical is Private limited company (BVBA/SPRL, legacy).
What is the annual revenue of Juvise Pharmaceutical?
The 2025 accounts of Juvise Pharmaceutical do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Juvise Pharmaceutical a reliable company?
Juvise Pharmaceutical is a registered Rechtspersoon with company number 0863.588.327 and can be verified through the official CBE database.
What is the credit limit of Juvise Pharmaceutical?
The estimated credit limit of Juvise Pharmaceutical is €0.
Is Juvise Pharmaceutical still active?
Juvise Pharmaceutical currently has the status "Normal situation" and is active.